Faculty of Medicine , Al Azhar university , Nasr city , Cairo , Egypt
Cairo, Egypt
NCT Number: NCT07795242
The aim of this observational study is to evaluate the diagnostic performance of an AI algorithm in the histopathological diagnosis of MF compared to certified dermatopathologists.
Trial opening soon.
Get NotifiedAll sexes
Observational
Cairo, Egypt
Mycosis fungoides (MF) is the most common form of primary cutaneous T-cell lymphoma. Its early histological features may overlap with benign inflammatory dermatoses, making diagnosis challenging.
This observational study aims to evaluate the diagnostic performance of HistoGPT in the histopathological diagnosis of MF compared with certified dermatopathologists.
H&E-stained skin biopsy slides will be digitized using a Leica Aperio GT450 whole-slide scanner at 40× magnification.
The resulting whole-slide images will be analyzed using HistoGPT, an AI-based histopathology platform.
The diagnostic performance of HistoGPT and certified dermatopathologists will be assessed and compared using appropriate diagnostic metrics, including accuracy, sensitivity, specificity, F1 score, and area under the ROC curve.
The findings of this study will help determine whether Artificial intelligence can serve as a diagnostic support tool for the histopathological diagnosis of mycosis fungoides.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Does not include intervention
Time frame: 1 year
Contact information is provided by the study sponsor or research team.
Al-Azhar University
Other
Evaluation of Artificial Intelligence Algorithms Performance in the Histopathological Diagnosis of Mycosis Fungoides
Acronym: AI\MF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07705386
Cutaneous Lymphoproliferative Diseases, Disease
Cairo, Egypt
View Trial DetailsNCT07060599
Adenocarcinoma, Artificial Intelligence (AI) in Diagnosis
Guangzhou, Guangdong, China
View Trial DetailsNCT07352475
Artificial Intelligence (AI) in Diagnosis, Clinical Decision-making
Lille, France
View Trial DetailsNCT07795801
Anal Cancer, Anus Diseases
Boston, Massachusetts, United States
View Trial Details